Health2Sync
$20.0M
Funding date
Valuation / Funding
No funding history available
Funding data has not been imported for this company yet
Current Valuation Metrics
Health2Sync is currently valued at N/A as of March 5, 2025. The company has raised a total of $42.5M in funding.
Investment Perspective
Health2Sync's valuation reflects investor confidence in the company's market position, growth potential, and ability to execute on its business model. Private market valuations are determined by primary funding rounds and secondary market transactions, which take into account financial performance, market conditions, and growth prospects.
What is Health2Sync Worth in 2025?
As of 2025, Health2Sync is valued at N/A, based on the company's Later Stage VC funding round in March 5, 2025. This valuation positions Health2Sync as one of the leading private companies in the sector.
Health2Sync Valuation History
Health2Sync's funding history demonstrates steady growth and investor confidence.
How Health2Sync Valuation is Determined
Private company valuations like Health2Sync's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including:
- Revenue growth and financial performance
- Market opportunity and total addressable market (TAM)
- Competitive positioning and market share
- Management team strength and execution capability
- Technology and intellectual property
- Industry trends and investor sentiment
Health2Sync Valuation FAQs
Is Health2Sync profitable?
Health2Sync has not publicly disclosed its profitability status. Many high-growth private companies prioritize market expansion and user growth over profitability in their early stages.
How does Health2Sync's valuation compare to competitors?
Health2Sync is valued at N/A, positioning it as a major player in the space. Secondary market pricing and private market transactions provide ongoing validation of this valuation.
When will Health2Sync IPO?
Health2Sync has not announced plans for an initial public offering. Until an IPO, investors can access Health2Sync shares through secondary market platforms.